about
Guanylate cyclase 2cGuanylate cyclase 2CNatriuretic peptide receptor 1Natriuretic peptide receptor 2Guanylate cyclase soluble subunit beta-2Guanylate cyclase 1 soluble subunit alpha 2Guanylate cyclase 1 soluble subunit alpha 1Guanylate cyclase 1 soluble subunit beta 1Adenylate cyclase 6Adenylate cyclase 3Adenylate cyclase 9Adenylate cyclase 5Adenylate cyclase 8Adenylate cyclase 7Adenylate cyclase 2Adenylate cyclase 1Adenylate cyclase 4Adenylate cyclase 10Guanylate cyclase 2F, retinalGuanylate cyclase 2D, retinalBrain adenylate cyclase 8Hypothetical protein CT_012Integral membrane protein CTL0267Guanylate cyclase 2eGuanylate cyclase 2gAdenylate cyclase 1Adenylate cyclase 7Adenylate cyclase 9Adenylate cyclase 5Adenylate cyclase 8Adenylate cyclase 6Adenylate cyclase type 2Adenylate cyclase 10Adenylate cyclase 3Adenylate cyclase 4Guanylate cyclase 1, soluble, beta 1Guanylate cyclase 1, soluble, alpha 1Natriuretic peptide receptor 1Natriuretic peptide receptor 2Hypothetical protein BB_0008
P680
Different chromosomal localization of two adenylyl cyclase genes expressed in human brainRegulation of cAMP responses by the G12/13 pathway converges on adenylyl cyclase VIIRegions on adenylyl cyclase VII required for selective regulation by the G13 pathwayZymosan activates protein kinase A via adenylyl cyclase VII to modulate innate immune responses during inflammationProstaglandin E receptor EP1 forms a complex with dopamine D1 receptor and directs D1-induced cAMP production to adenylyl cyclase 7 through mobilizing G(βγ) subunits in human embryonic kidney 293T cells.
P921
Q14888940-D1B01641-3996-4EFE-A53E-9B9E4B7C0BD1Q1552797-E0B45716-D14A-47DD-B52C-60A13BEF0324Q21105144-3D4F17EF-E2CC-4365-96E0-88FC4997EC1DQ21105148-4E8BEDDD-4071-440B-9944-0932545F8E68Q21110348-EEA4729E-7A96-4601-85B5-829EABF53BBFQ21110352-73D40DD4-960C-4CFC-9A5F-83918F5D5C89Q21110358-03CCB5AE-8665-4114-B0F6-30ECDEC08BD4Q21110359-1D818C0F-705B-40FD-9D57-F9F1EC8FFD37Q21111191-9C56AE95-2543-4490-A0F9-37101954566BQ21111191-F08B740A-A32C-4D95-8C6C-D8E96E3ED6BFQ21111192-3BDF2E02-2780-4923-84AF-2EF82F32E021Q21111192-E17E5348-7888-41FF-9F63-09CEF593D06EQ21111193-1607D768-1378-4E70-9021-5ABAD73104F7Q21111193-CF3EB251-BD74-4E41-985D-B04A7E8BD241Q21111195-5B4EE27C-E646-49ED-B47D-CC848CEA1E9DQ21111195-650BEFA0-1EE5-4D5C-9185-315FAFF3CC58Q21111198-4357F75F-089F-46AD-BE40-CB163A4DB162Q21111198-479408F4-42DF-41B7-81B8-5C734B48EBB5Q21111200-686B7690-E35B-42CF-8E6C-A221B8305EF1Q21111200-7C632A87-3186-43EA-94F5-32C43F030626Q21111200-DDE16368-8093-4241-9469-3D6E9A6026A7Q21111200-E6C9636E-BCFC-4FF9-ADC3-EA15B8A82F8BQ21111201-5872E38B-B742-4D42-87FA-FEB433BCFAF0Q21111201-BEBD9EF6-8819-4478-9888-3E8A960AFCA5Q21111202-222FD4FD-C5B7-417E-AC92-A958192ED148Q21111202-51BA6BCB-0030-4E29-8560-3BD8A7B1D1BAQ21111202-D7621B92-BC58-4E26-93B7-C564886E74E1Q21111211-678F3EFC-1591-4683-932E-3414529A9121Q21111211-E6DEBA66-CDD3-4F58-8D37-6337F303658EQ21111219-4981AFB4-3039-42D6-984D-A4139180CDB3Q21111219-C61603B9-66A2-4BAB-8428-0FD1ECC71E14Q21119036-4F61F51B-1004-456C-9829-4BDF5C5AFA6EQ21119037-6DFFA9C8-EA5E-4858-835C-623C75140EB1Q21137632-CCCC3632-D90A-4B08-9891-29F7414B23C8Q21166993-3C616A64-22A9-494F-A110-233EC171EDC7Q21166993-9C3BA1E1-D3FC-43CE-A1D5-C93B9DD6F0CAQ21172507-52430554-F496-4A8A-A840-AEB523BD36D4Q21433652-802E94E9-4576-44AD-9BEF-1D38CC431A89Q21433653-47102352-70D3-48B7-8389-7E5715825891Q21495333-BC69DEF5-C06E-4423-A0B6-13EE5D72B46E
P680
description
Catalysis of the reaction: ATP = 3',5'-cyclic AMP + diphosphate.
@en
biologisch proces
@nl
name
adenylate cyclase activity
@en
type
label
adenylate cyclase activity
@en
altLabel
3',5'-cyclic AMP synthetase activity
@en
ATP diphosphate-lyase (cyclizing) activity
@en
ATP diphosphate-lyase (cyclizing; 3',5'-cyclic-AMP-forming) activity
@en
ATP pyrophosphate-lyase activity
@en
GO:0004016
@en
adenyl cyclase activity
@en
adenylyl cyclase activity
@en
adenylylcyclase activity
@en
prefLabel
adenylate cyclase activity
@en
P2888
P591
P686
GO:0004016